A state COVID-19 rapid test exchange program has ceased operation, and more states are stockpiling surplus supplies instead of donating to others with shortages, Kaiser Health News reported Jan. 31.
Category: Supply Chain
Stryker says nearly 10% of its knee business is in ASCs
ASCs comprised nearly 10 percent of Stryker’s knee business last year, and the company expects the move of orthopedic surgeries to the outpatient setting will continue.
Patients with this sinus implant fare better after surgery, study says
Intersect ENT’s Propel sinus implant is associated with better outcomes for endoscopic sinus surgery patients than undergoing the same procedure without the implant, according to a study published Jan. 20 in Current Medical Research and Opinion.
Medical organizations call on public to donate amid blood crisis
The American Hospital Association, American Medical Association and American Nurses Association on Jan. 27 called on those who are able to donate blood. The joint statement comes about two weeks after the American Red Cross declared the nation’s first …
6 executives on managing supply chain disruptions
Supply chain issues exacerbated by the COVID-19 pandemic have led leaders at health systems across the U.S. to develop innovative solutions to manage disruptions.
Houston company to develop 5-layer COVID-19 mask for kids
Houston-based respirator manufacturer Aegle plans to develop a five-layer children’s mask to protect against the transmission of COVID-19, other airborne particles and pollution from wildfires, the company said Jan. 27.
10 medical device companies with the biggest pandemic revenue gains
The COVID-19 pandemic struck the medical device industry harder than most in fiscal year 2021.
White House launches free COVID-19 test kits & more supply chain updates
Seven supply chain updates from the last two weeks:
Top 15 medtech companies by revenue | 2021
The COVID-19 pandemic struck the medical device industry harder than most in fiscal year 2021.
Available but ineffective antibody treatment still in use in some states
The monoclonal antibody therapies made by Regeneron and Eli Lilly, which the omicron coronavirus variant has essentially rendered useless, are still in high use in 12 states, Kaiser Health News reported Jan. 21.
